<div id="readability-page-1"><p>Thoroughbred Financial Services LLC cut its position in  UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 25.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,185 shares of the healthcare conglomerate's stock after selling 4,096 shares during the quarter. Thoroughbred Financial Services LLC's holdings in UnitedHealth Group were worth $6,164,000 at the end of the most recent reporting period.</p><div><p><span></span><span>Get <strong>UnitedHealth Group</strong> alerts:</span></p></div><ul><li>MarketBeat Week in Review – 02/24 - 02/28</li></ul><p>Several other large investors also recently added to or reduced their stakes in UNH. NewSquare Capital LLC purchased a new position in shares of  UnitedHealth Group in the fourth quarter valued at $25,000.  AlphaMark Advisors LLC purchased a new stake in shares of  UnitedHealth Group in the fourth quarter worth about $30,000.  Promus Capital LLC bought a new stake in  UnitedHealth Group during the 4th quarter worth approximately $32,000.  Pillar Financial Advisors LLC bought a new position in  UnitedHealth Group in the 4th quarter valued at $40,000.  Finally, DecisionPoint Financial LLC increased its holdings in shares of  UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock worth $52,000 after purchasing an additional 62 shares during the period. Hedge funds and other institutional investors own  87.86% of the company's stock. </p><h2>Insider Activity</h2><p>In related news, Director Timothy Patrick Flynn bought 1,000 shares of the company's stock in a transaction on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink. Company insiders own  0.33% of the company's stock. </p><h2>Analysts Set New Price Targets</h2><ul><li>3 Beaten Down Healthcare Stocks Recovering in 2025</li></ul><p>Several analysts have weighed in on the company. Stephens raised their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an &#34;overweight&#34; rating in a report on Thursday, December 5th. HSBC upgraded shares of UnitedHealth Group from a &#34;hold&#34; rating to a &#34;buy&#34; rating and set a $595.00 target price for the company in a research report on Friday, January 10th. Piper Sandler dropped their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an &#34;overweight&#34; rating for the company in a report on Thursday, January 2nd. Cantor Fitzgerald  reaffirmed an &#34;overweight&#34; rating and set a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Oppenheimer raised their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an &#34;outperform&#34; rating in a report on Friday, December 6th. Twenty equities research analysts have rated the stock with a buy rating and two have issued  a strong buy rating to the company's stock. According to MarketBeat.com, UnitedHealth Group  has an average rating of &#34;Buy&#34; and a consensus price target of $629.32.</p><p><b>View Our Latest Report on UnitedHealth Group</b></p><h2>UnitedHealth Group Trading Up 3.4 %</h2><ul><li>UnitedHealth's RSI Suggests It Is Extremely Oversold </li></ul><p>NYSE UNH opened at $540.87 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The stock has a market cap of $494.74 billion, a P/E ratio of 34.89, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The stock has a 50 day simple moving average of $509.39 and a two-hundred day simple moving average of $542.82. </p><p>UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group's quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $5.83 earnings per share.  On average, analysts forecast that  UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year. </p><h2>UnitedHealth Group Dividend Announcement</h2><p>The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date of this dividend  was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.19%. </p><h2>About UnitedHealth Group</h2> (Free Report)<p>UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.</p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than UnitedHealth Group</li><li>Learn Technical Analysis Skills to Master the Stock Market</li><li>Shares of RH Down Nearly 40%: Where Investors Can Turn To Now</li><li>REIT Stocks - Best REIT Stocks to Add to Your Portfolio Today</li><li>Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian</li><li>How Investors Can Find the Best Cheap Dividend Stocks</li><li>Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2><p>Before you consider UnitedHealth Group, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.</p><p>While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Thoroughbred Financial Services LLC reduced its stake in UnitedHealth Group (NYSE:UNH) by 25.2% in Q4, now holding 12,185 shares valued at $6.16 million. Other investors also adjusted their positions, with several new stakes established. Analysts have set new price targets for UNH, with ratings mostly at "buy" or "overweight." The stock opened at $540.87, showing a market cap of $494.74 billion and a P/E ratio of 34.89. UnitedHealth reported Q4 earnings of $6.81 per share, exceeding estimates, with revenue of $100.81 billion.</p>

Thoroughbred Financial Services LLC Decreases Position in UnitedHealth Group Incorporated (NYSE:UNH)